News Conference News VIVA 2024 Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II L.A. McKeown November 06, 2024
News Conference News ISET 2024 How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy Caitlin E. Cox January 24, 2024
News Conference News VIVA 2023 New Carotid Stent Systems Associated With Low Stroke Risk L.A. McKeown November 09, 2023
News Conference News VIVA 2023 PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI L.A. McKeown November 01, 2023
News Conference News LINC 2023 What Works, What’s Noise? Novel Approaches Offer Hope in CLTI L.A. McKeown June 07, 2023
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Opinion Editor's Corner ESC 2022 What’s Going to Be Hot at ESC 2022? Shelley Wood August 22, 2022
News Conference News VIVA 2021 Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI L.A. McKeown October 08, 2021
News Conference News VIVA 2020 BVS Reboot? Signs of Durability to 2 Years in Critical Limb-Threatening Ischemia L.A. McKeown November 11, 2020
News Conference News VIVA 2020 DISRUPT PAD III: Lithotripsy Shows Promise in Heavily Calcified PAD L.A. McKeown November 09, 2020
News Conference News TCT 2017 TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More Shelley Wood October 20, 2017
News Conference News VIVA 2017 EVAR Outcomes Equivalent Between Men and Women, Registries Show L.A. McKeown September 14, 2017